Semaglutide 10mg: GLP-1 Peptide

Semaglutide is a synthetic research peptide belonging to the GLP-1 (glucagon-like peptide-1) receptor agonist class. It is widely studied for its effects on glucose regulation, metabolic signaling, gastric emptying, and energy balance in preclinical and in-vitro research models.

Designed with enhanced stability and a prolonged half-life, Semaglutide is an advanced tool for studying incretin-based metabolic pathways.

Scientific Background

Semaglutide is an analog of the native GLP-1 hormone, engineered to resist enzymatic breakdown and maintain prolonged receptor activation. In experimental systems, GLP-1 receptor activation is known to influence:

• Insulin sensitivity
• Glucose uptake
• Appetite-regulation pathways
• Gastric emptying speed
• Energy metabolism

By modifying the native GLP-1 structure, Semaglutide displays significantly higher stability and receptor affinity compared to earlier incretin analogues.

Research Areas of Interest

All information below is strictly for laboratory, scientific, and in-vitro research discussion only.

1. Glucose Regulation Pathways

Semaglutide is widely used in research models to study:

• Glucose homeostasis
• Insulin modulation
• Pancreatic β-cell signaling

2. Metabolic & Endocrine Research

Its GLP-1 receptor activity makes it valuable for investigating:

• Metabolic rate changes
• Appetite signaling
• Hormonal crosstalk in metabolic tissues

3. Gastrointestinal Function Models

Research also explores potential roles in:

• Gastric emptying
• Gut-brain communication
• Intestinal hormone signaling

4. Energy Balance & Weight-Regulation Systems

Preclinical models evaluate Semaglutide’s impact on:

• Energy expenditure
• Central appetite-regulation pathways
• Caloric intake modulation

5. Comparison to Other Incretin Pathways

Semaglutide is frequently studied alongside:

• Tirzepatide (GLP-1/GIP dual agonist)
• Retatrutide (GLP-1/GIP/Glucagon triple agonist)
• Liraglutide (earlier GLP-1 analog)

This allows researchers to evaluate differences in potency, stability, and receptor engagement.

Molecular Profile

• Peptide: Semaglutide
• Type: GLP-1 Receptor Agonist
• Sequence Length: 31 amino acids (synthetic analogue with modifications)
• Form: Lyophilized powder
• Purity: ≥ 98% (HPLC tested)

Semaglutide includes proprietary fatty-acid and amino-acid modifications to extend half-life and is not typically displayed as a full open-source sequence by peptide suppliers.

Storage & Stability

• Store lyophilized peptide at –20°C
• Protect from heat, moisture, and light
• Use reconstituted material promptly or store following laboratory protocol
• Avoid repeated freeze-thaw cycles

Each 3ml vial is formulated with 10mg of highly purified (>99%) lyophilized Semaglutide, produced in sterile environments that meet research-grade standards. Prime Peptides validates every batch through third-party laboratory testing to ensure exact molecular composition, stable peptide structure, and consistent results suitable for a wide range of experimental designs.